Board of Directors
Håkon Sæterøy
Executive Chairman of the Board
Håkon Sæterøy is the CEO & Chairman of IC Targets AS, and a Co-founder of the company. Håkon is Managing Director of Investor Corporate AS, the second largest shareholder of IC Targets AS. He is a Co-founder and currently serves as CEO of Alzheimer´s diagnostics company Pre Diagnostics AS. Håkon was Executive Chairman of listed diagnostic company DiaGenic ASA from 2002-2010, Executive Chairman of drug development company Serodus ASA from 2008-2012 and chairman/board member of diagnostic company Skannex AS from 2008-2014.
With more than 30 years of experience in management, corporate finance and business development, Håkon has an extensive international network. He has worked with corporate finance in Norwegian investment banks for 12 years and continued the financing and M&A consultancy business in his own company Investor Corporate AS.
Håkon has been a shareholder and board member in several life science companies in Norway. He was a board member of Nansen Neuroscience Network from 2010-2020 (chairman from 2010-2012) and was a board member of Oslo Cancer Cluster (2007-2014). Sæterøy is “siviløkonom” from NHH (Norwegian School of Economics), Bergen – a 4 year programme in economics and business administration consisting of three years at bachelor level and one year at master level.
Jonny Østensen
Board Member
Jonny Østensen is a board member and Chief Scientific Officer of IC Targets AS. He has more than 30 years’ experience in research, development & innovation within pharmaceutical industry and technology transfer.
Jonny was Medical Advisor of Nycomed Imaging, VP Biology of Amersham Health and GE Healthcare (1990-2008) with responsibility for global biology research. In 2008 he joined Inven2 as VP Innovation to assess and commercialize innovative research conducted at the University of Oslo, Oslo University Hospital and the health trusts under the South-Eastern Norway Regional Health Authority. Jonny was Board Director for the Cancer Stem Cell Innovation Center (CAST)-SFI from 2011 to 2015.
Jonny is author of 31 peer-reviewed publications and inventor of 55 patent families related to diagnostic imaging technologies. Since 2021, he has been employed by IC Targets as leader for the cardiology project. He was elected as a Board Member in 2024. Jonny holds an MD, PhD from the University of Oslo.
Kristin Sandereid
Board Member
Kristin Sandereid has more than 20 years’ experience from business development within MedTech and technology transfers. Most recently from Removaid AS, a company developing and selling medical devices for removal of subdermal implants.
Sandereid holds a degree in molecular biology. She has extensive experience from international sales of technology, building business models and collecting funding for start-up companies.